Analysis of more than 200 CRC specimens revealed that the TCF4 gene was inactivated in 31% of microsatellite-unstable (MSI) and 12% of microsatellite-stable (MSS) cancers. This evidence concerns the gene TCF4 and colorectal carcinoma.